Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer-Reference-Cited by-同舟云学术

Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer

Published:2011-01 Issue:2 Volume:300 Page:122-133
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Li,Chen Hongmin,Liu FengHua,Madigan Michele C.,Power Carl A.,Hao Jingli,Patterson Kate I.,Pourgholami Mohammad H.,O’Brien Philippa M.,Perkins Alan C.,Li Yong

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Cancer statistics, 2009;Jemal;CA. Cancer J. Clin.,2009

2. Recent advances in the treatment of epithelial ovarian cancer;Harries;Exp. Opin. Invest. Drugs,2001

3. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance;Wang;Gynecol. Oncol.,2007

4. Mucins in cancer: protection and control of the cell surface;Hollingsworth;Nat. Rev.,2004

5. MUC1 mucin expression in transitional cell carcinoma of the bladder;Hughes;J. Urol. Pathol.,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paeoniflorigenone inhibits ovarian cancer metastasis through targeting the MUC1/Wnt/β‑catenin pathway;International Journal of Molecular Medicine;2024-05-21

2. Simple recombinant monoclonal antibody production fromE. coli;2024-04-17

3. Immunoengineering can overcome the glycocalyx armour of cancer cells;Nature Materials;2024-02-15

4. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells;Journal of Pharmaceutical Sciences;2023-05

5. A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)2 and taxotere in ovarian cancer cells;Communications Biology;2022-09-21